Novo Nordisk A/S Calls for Extraordinary General Meeting to Elect New Board Members

Novo Nordisk A/S has announced an Extraordinary General Meeting (EGM) to be held on November 14, 2025, at 14:00 CET. The meeting will be conducted entirely electronically, allowing shareholders to participate virtually via an IT application. The primary agenda item is the election of new members to the Board of Directors. Shareholders are encouraged to exercise their rights by submitting proxies or votes by correspondence in advance. The meeting notice includes detailed proposals for the election of a new Chair, Vice Chair, and other Board members. Novo Nordisk, a global healthcare company, emphasizes its commitment to driving change to defeat serious chronic diseases and continues to expand its reach in the pharmaceutical market.